報價延遲最少15分鐘:2026/07/18 14:25 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
39.79 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
1.14/1.66
|
|
企業價值
47.25B
|
| 資產負債 |
|
每股賬面淨值
13.33
|
| 現金流量 |
|
現金流量率
0.04
|
| 損益表 |
|
收益
28.43B
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families-including front-line care, surgical solutions, and laboratory and diagnostics-as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025. |
